Thomson Reuters (TRI)
(Delayed Data from NYSE)
$152.63 USD
-0.96 (-0.63%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $152.62 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
TRI 152.63 -0.96(-0.63%)
Will TRI be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for TRI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TRI
Why Thomson Reuters (TRI) Could Beat Earnings Estimates Again
KD or TRI: Which Is the Better Value Stock Right Now?
TRI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Comcast's (CMCSA) AudienceXpress, iSpot Team Up for TV Marketing
AMADY or TRI: Which Is the Better Value Stock Right Now?
Compared to Estimates, Thomson Reuters (TRI) Q4 Earnings: A Look at Key Metrics
Other News for TRI
SMALL-CAP WINNERS & LOSERS: LSL Property rises as swings to profit
Trifast plc Surpasses FY24 Financial Expectations
GET READY: AstraZeneca, Barclays, J Sainsbury, Relx, Weir at 0700 BST
Cove Street Capital Q1 2024 Letter To Shareholders
UK earnings, trading statements calendar - next 7 days